Allergan Fights To Keep IPR Extortion Fight In Federal Court
Allergan Inc. fought to keep its suit alleging Ferrum Ferro Capital LLC's bid to invalidate a patent for a glaucoma drug under the America Invents Act amounts to extortion in California...To view the full article, register now.
Already a subscriber? Click here to view full article